Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01335880 · ClinicalTrials.gov registry record · NA

Helping People to Exercise Regularly

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
117
Enrollment target

NCT01335880: Completed NA study, sponsored by University of Pennsylvania.

NCT01335880 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 117 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01335880, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target

Study Summary

This study tests two different incentive mechanisms to induce members of a particular urban senior center to attend more exercise classes. Coupons for future use are given to participants who attend an exercise class and will be redeemable within either a one week or three month time period, depending on which experimental group the participant is assigned to. Frequency of exercise class attendance at the end of 2 months will be the primary outcome.

Interventions

  • BEHAVIORAL Coupons for use within the next week
  • BEHAVIORAL Coupons for use within the next 3 months

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2011-04
Est. Completion 2012-07
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT01335880 record still lists

NCT01335880 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Coupons for use within the next week is the first listed.

NCT01335880 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01335880 about?

NCT01335880 is a clinical study titled "Helping People to Exercise Regularly". This study tests two different incentive mechanisms to induce members of a particular urban senior center to attend more exercise classes. Coupons for future use are given to participants who attend an exercise class and will be redeemable within either a one week or three month time period, dependi...

What is the current status of trial NCT01335880?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2011-04. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01335880?

The interventions under investigation include: Coupons for use within the next week (BEHAVIORAL), Coupons for use within the next 3 months (BEHAVIORAL).

Who is sponsoring clinical trial NCT01335880?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01335880's enrollment target sits among peer trials

117 807th of 2000 higher than 1,193 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03539822 · 117 participants · Phase 1

    Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

  • NCT03786692 · 117 participants · Phase 2

    Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

  • NCT04479696 · 117 participants · NA

    Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

  • NCT04940585 · 117 participants · NA

    ROSE in Sunset Park

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01335880, the US trial registry maintained by the National Library of Medicine. NCT01335880 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.